Very exciting!The authors describe the discovery of a live virus-vectored #SARSCoV2 vaxx candidate using the YF17D vaccine as vector to express a non-cleavable pre-fusion form of the SARS-CoV-2 Spike antigen.
Been waiting for this, let me tell you why
https://www.nature.com/articles/s41586-020-3035-9
Yellow Fever 17D=small RNA live-attenuated virus
YF17D vaccine induces broad polyfunctional humoral & cell-mediated immune responses that may result in life-long protection following a single vaccine dose in nearly all vaccinees! Yes that's right - Lifelong
These favorable characteristics translate also to vectored-vaccines based on the YF17D backbone!!!
YF17D is used as vector in two licensed human vaccines, generated by swapping genes encoding the YF17D surface antigens for JEV or dengue viruses.
The authors show safety, immunogenicity and efficacy after a single dose in several animal models including hamsters, mice and macaques.

Bring on phase one trials in humans. This is very very good #COVID19 vaccine news. Also did I mention vaccine stable at 2-8C?

Read on Twitter